NCT06778317

mSEPT9 Biomarker for Predicting Hepatocellular Carcinoma Occurrence in Patients With Cirrhosis

RecruitingOBSERVATIONAL

Trial Details

Start: 2025-06-03Est. Completion: 2033-06-03

Enrollment target: 400 participants

Locations

Contact

Hepatocellular Carcinoma (HCC)Artificial IntelligentAdjuvant ChemoradiotherapyTACELenvatinibLiver Surgery

Hepatocellular carcinoma (HCC) is a high-mortality global malignancy with a heavy disease burden in China. Although cura…

Hangzhou, ChinaEst. completion Jan 1, 2029

Fatty Liver

The newly adapted definition for MASLD includes evidence for hepatic steatosis by imaging or biopsy with at least one of…

Sohag, EgyptEst. completion Jan 1, 2027

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.